Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
IAC
EXPRESS
Weekly Email News and Information
Join more than 50,000 subscribers today!
Stay current! Every week, IAC Express is delivered directly to your email box. It features important immunization developments, such as the latest vaccine recommendations and licensures, important journal articles, practical vaccination resources, conference announcements, and more.
READ CURRENT ISSUE: IAC Express Special Edition
Ask the Experts: CDC Experts Answer Your Questions
Issue 1336: November 17, 2017
The questions and answers in this edition of IAC Express first appeared in the November 2017 issue of Needle Tips.
IAC extends thanks to our experts: Andrew T. Kroger, MD, MPH; Candice L. Robinson, MD, MPH; Raymond A. Strikas, MD, MPH, FACP, FIDSA; Donna L. Weaver, RN, MN; and Jessie Wing, MD, MPH, all from the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC).
Influenza Vaccines
Q: What’s new in the 2017–18 influenza vaccine recommendations?
Q: Which influenza vaccines will be available during the 2017–18 influenza season?
Q: Who is recommended to be vaccinated against influenza?
Q: When should influenza vaccine be given?
Q: When administering influenza vaccine, is giving patients a VIS mandatory or is it only “recommended”?
Q: Which influenza vaccines can we give to children?
Q: Please provide details about the use of FluLaval influenza vaccine in children younger than 3 years.
Q: Which children younger than age 9 years will need 2 doses of influenza vaccine in this influenza season?
Q: Can a child 6 through 35 months of age who needs 2 doses of influenza vaccine this season receive one each of Fluzone and FluLaval vaccine?
Q: If a child receives Fluzone vaccine (0.25 mL) at age 34 or 35 months for the first time and then returns for the second dose at age 37 months, should we give another 0.25 mL dose of Fluzone or should we give the 0.5 mL dose that is indicated for ages 3 and older?
Q: A 1-year-old was inadvertently given a 0.25 mL dose of FluLaval rather than the recommended 0.5 mL dose. What should we do?
Q: Is influenza vaccine recommended for pregnant women?
Q: I heard that a recent study suggested an increase in miscarriage among women who received inactivated influenza vaccine. Please provide details.
Q: Please tell me about Fluad, the new influenza vaccine for people age 65 years and older.
Q: A study published in 2014 found that the injectable vaccine Fluzone High-Dose protects people 65 years and older better than standard-dose Fluzone. Does ACIP preferentially recommend use of Fluzone High-Dose for all people age 65 years and older?
Q: May Fluzone High-Dose or Fluad be administered to patients younger than age 65 years?
Q: What is the latest ACIP guidance on influenza vaccination and egg allergy?
Q: Should staff at drive-through influenza vaccination clinics encourage drivers to park and wait for 15 minutes after vaccination to make sure they don't have a syncopal (fainting) episode?
Q: When removing both pediatric (0.25 mL) and adult (0.5 mL) doses from a multi-dose vial of Fluzone, we can get more than 10 doses from the 5.0 mL vial. Can we continue to remove doses from the vial until it is empty?
Q: We inadvertently administered intradermal influenza vaccine to a patient who is outside the recommended age range of 18 through 64 years. What should we do now?
Q: How should influenza vaccines be stored?
Q: Some of my patients refuse influenza vaccination because they insist they "got the flu" after receiving the injectable vaccine in the past. What can I tell them?
Q: Does ACIP recommend one influenza product over another for pregnant women?
Q: If quadrivalent vaccine includes one additional strain, why isn't it preferred for use over trivalent vaccines?
Q: Sometimes patients age 65 years and older who have received the standard-dose influenza vaccine hear about the high-dose (Fluzone High-Dose) or adjuvanted vaccine (Fluad) and want to receive that, too. Is this okay to administer?
Q: The influenza VIS states that giving pneumococcal conjugate vaccine and inactivated influenza vaccine simultaneously may increase the risk of febrile seizures. Can we continue to give these two vaccines at the same time?
Q: The pneumococcal conjugate vaccine (PCV13) package insert says that in adults, antibody responses to PCV13 were diminished when given with inactivated influenza vaccine. Does this mean we should not give PCV13 and influenza vaccine at the same visit?
Q: Some of our patients believe that they have had reactions to influenza vaccine in the past and request the dose to be split into 2 doses administered on different days. Is this an acceptable practice?
Q: Is it acceptable to draw up vaccine into syringes at the beginning of the day? If it isn't, how much in advance can this be done?
 
 
Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
Read Current Issue
2017 Issues
2016 Issues: July - December
2016 Issues: January - June
2015 Issues
2014 Issues
2013 Issues
2012 -1997 Issues
Praise for IAC Express
Help
Disclaimer
Editor: Deborah L. Wexler, MD
Managing Editor: Teresa Anderson, DDS, MPH
Consulting Editor: Marian Deegan, JD
Assistant Managing Editor:
Liv Augusta Anderson, MPP
Publications
Needle Tips
Vaccinate Adults
>> learn more
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
ACIP RECOMMENDATIONS
ADDITIONAL RESOURCES
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Combination Vaccines
Diphtheria
Hepatitis A
Hepatitis B
Question of the Week
Vaccine Storage and Handling
What's New
>> view all
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR
CDC INFORMATION
CDC SCHEDULES
CLINIC RESOURCES
Administering Vaccines
Documenting Vaccination
Scheduling Vaccination
Screening for Contraindications
Storage & Handling
Vaccine Recommendations
>> view all
COALITIONS
CONTRIBUTE TO IAC
DEAR COLLEAGUE LETTER
HPV VACCINE
DEAR COLLEAGUE LETTER
MCV4 DOSE #2
DISEASES & VACCINES
Diphtheria
Hepatitis A
Hepatitis B
Influenza
Varicella
>> view all
DONATE TO IAC
EMAIL NEWS SERVICES
EDUCATIONAL MATERIALS
FAQs
FAVORITES (WEB SECTIONS)
FDA PRODUCT APPROVALS
GIVE BIRTH TO THE END OF
HEP B
HANDOUTS FOR PATIENTS &
STAFF
Administering Vaccines
Adult Vaccination
Documenting Vaccinations
Managing Vaccine Reactions
Parent Handouts
Patient Schedules
Questions & Answers
Recommendations
Screening Checklists
Standing Orders
Storage & Handling
Supplies Checklist
Talking with Parents
Temperature Logs
Top Handouts
Translations
Vaccine Index
>> view all
HEPATITIS B BIRTH DOSE
HONOR ROLLS
HepB Birth Dose
Influenza Vaccination for HCP
IAC EXPRESS
IMAGES
IMMUNIZATION TECHNIQUES
DVD
LAMINATED SCHEDULES
MANUFACTURERS
NATIONAL ADULT & INFLUENZA IMMUNIZATION SUMMIT
NEEDLE TIPS
NEWS & INFORMATION
OFFICIAL RELEASES
ACIP
CDC
FDA
>> view all
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
POCKET GUIDES
POWERPOINT SLIDE SETS
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IAC Express
Needle Tips
Vaccinate Adults
THE PURPLE BOOK
QUESTION OF THE WEEK
REGISTRIES
RESOURCE DIRECTORY
SHOP IAC
Immunization Techniques DVD
Laminated Schedules
Patient Record Cards
The Vaccine Handbook:
  A Practical Guide for Clinicians
>> view all
SITE MAP
SLIDE SETS
STANDING ORDERS TEMPLATES
STATE INFORMATION
State Websites
State Laws
State Immunization Managers
>> view all
SUBSCRIBE
SUPPORT IAC
TECHNICALLY SPEAKING
TRANSLATE FOR IAC
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE REPORTS
Chickenpox
Diphtheria
Hepatitis A
Hepatitis B
>> view all
VACCINATE ADULTS
VACCINE CONCERNS
Adjuvants & Ingredients
Alternative Medicine
Autism
Importance of Vaccination
>> view all
THE VACCINE HANDBOOK: A PRACTICAL GUIDE FOR CLINICIANS
VACCINE INFORMATION STATEMENTS
Translations
Vaccine Index
>> view all
VACCINE MANUFACTURERS
VACCINE POLICY & LICENSURE
ACIP
FDA
WHO
>> view all
VACCINE SAFETY
VACCINES & DISEASES
VIDEOS (VIDEO OF THE WEEK)
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs
Web Sections
>> view all
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.